Authors: HELLKAMP AS SHAFER SR CAMPBELL CL BAY JM FISCUS DA HESS GR MCQUAID BF MUNSTER MJ OLSON GL PECK SL EASTERLING KN SIDIK K TOOLEY MB

Citation: As. Hellkamp et al., ASSESSMENT OF THE CONDITION OF AGRICULTURAL LANDS IN 5 MID-ATLANTIC STATES, Environmental monitoring and assessment, 51(1-2), 1998, pp. 317-324

Authors: BLANKENSHIP JC HELLKAMP AS AGUIRRE FV DEMKO SL TOPOL EJ CALIFF RM

Citation: Jc. Blankenship et al., VASCULAR ACCESS SITE COMPLICATIONS AFTER PERCUTANEOUS CORONARY INTERVENTION WITH ABCIXIMAB IN THE EVALUATION OF C7E3 FOR THE PREVENTION OF ISCHEMIC COMPLICATIONS (EPIC) TRIAL, The American journal of cardiology, 81(1), 1998, pp. 36-40

Authors: VORCHHEIMER DA BARUCH L DEPERALTA ET GUZMAN IC HAYES RM HELLKAMP AS GRANGER CB TOPOL EJ CALIFF RM

Citation: Da. Vorchheimer et al., WEIGHT ADJUSTED ANTITHROMBOTIC REGIMENS ELIMINATE THE NITROGLYCERIN-ANTITHROMBOTIC INTERACTION, Journal of the American College of Cardiology, 29(2), 1997, pp. 3453-3453

Authors: ALEXANDER KP PETERSON ED HELLKAMP AS GRANGER CB TOPOL EJ CALIFF RM

Citation: Kp. Alexander et al., EARLY CATHETERIZATION IS STANDARD STRATEGY IN UNSTABLE ANGINA NQWMI -RESULTS FROM GUSTO IIB/, Journal of the American College of Cardiology, 29(2), 1997, pp. 5614-5614

Authors: BLANKENSHIP JC HELLKAMP AS DEMKO SL AGUIRRE FV TOPOL EJ CALIFF RM

Citation: Jc. Blankenship et al., VASCULAR ACCESS SITE COMPLICATIONS AFTER PERCUTANEOUS CORONARY INTERVENTION WITH GLYCOPROTEIN IIB IIIA RECEPTOR INHIBITOR THERAPY IN THE EPIC TRIAL/, Journal of the American College of Cardiology, 29(2), 1997, pp. 99310-99310